Cost Effectiveness of Calcium Supplement in Reducing Preeclampsia-Related Maternal Mortality

Documentos FCE CID Escuela de Economía N° 34 - Facultad de Ciencias Económicas de la Universidad Nacional de Colombia

38 Pages Posted: 14 Apr 2013

See all articles by Liliana Chicaíza

Liliana Chicaíza

Escuela de Administración de Empresas y Contaduría Pública

Mario García Molina

National University of Colombia - Department of Economics

Sandra Oviedo

National University of Colombia

José Urrego

National University of Colombia

Carlos Rincón

National University of Colombia

Jorge Rubio-Romero

National University of Colombia

Pío Gómez

National University of Colombia

Date Written: July 11, 2012

Abstract

Objective: To estimate the cost-effectiveness of the supply of calcium of 1200mg per day from the week 14 of pregnancy to all pregnant women compared to not supplying it to reduce the incidence of preeclampsia.

Methods: A decision tree was built in TreeAge® with outcome measured in life years gained (LYG) associated to the reduction in maternal deaths. The costs were included from the perspective of the Health System in Colombia. Pharmaceutical costs were obtained from 2008 SISMED (1) and the value of the procedures was calculated by adjusting the values of Tariff Manual ISS 2001 30% (2), these values were compared with information of costs supplied by three EPS. All costs are expressed in Colombian pesos of 2010. The discount rate was 0%. It was performed sensitivity univariate and probabilistic analyzes for costs and effectiveness.

Results: Compared to no intervention, calcium supplement is a dominant alternative. If the incidence of preeclampsia is lower than 51.7 per 1000 pregnant women or the cost per tablet of calcium of 600mg is greater than $454, calcium supplement is no longer a cost-effective alternative in Colombia for a threshold of 3 times the GDP per capita in Colombia of 2010 by LYG, equal to $36,143,550.

Conclusions: Supply of calcium to all pregnant women from week 14 of gestation is a dominant alternative compared to no intervention, which saves 200 LYG, while it decreases costs in the order of $5,304 million pesos per 100.000 pregnant women.

Note: Downloadable document is in Spanish.

Keywords: Cost-benefit analysis, Cost effectiveness, Health economics, Pregnancy

JEL Classification: D61, I10, I12, I19

Suggested Citation

Chicaíza, Liliana and García Molina, Mario and Oviedo, Sandra and Urrego, José and Rincón, Carlos and Rubio-Romero, Jorge and Gómez, Pío, Cost Effectiveness of Calcium Supplement in Reducing Preeclampsia-Related Maternal Mortality (July 11, 2012). Documentos FCE CID Escuela de Economía N° 34 - Facultad de Ciencias Económicas de la Universidad Nacional de Colombia , Available at SSRN: https://ssrn.com/abstract=2194574 or http://dx.doi.org/10.2139/ssrn.2194574

Liliana Chicaíza (Contact Author)

Escuela de Administración de Empresas y Contaduría Pública ( email )

Carrera 30 45-03
Bogota, None
Colombia

Mario García Molina

National University of Colombia - Department of Economics ( email )

Carrera 30 Calle 45 Ciudad Universitaria
Bogotá
Colombia

HOME PAGE: http://www.unal.edu.co

Sandra Oviedo

National University of Colombia ( email )

Carrera 30 45-03
Bogota, None
Colombia

José Urrego

National University of Colombia ( email )

Carrera 30 45-03
Bogota, None
Colombia

Carlos Rincón

National University of Colombia ( email )

Carrera 30 45-03
Bogota, None
Colombia

Jorge Rubio-Romero

National University of Colombia ( email )

Carrera 30 45-03
Bogota, None
Colombia

Pío Gómez

National University of Colombia ( email )

Carrera 30 45-03
Bogota, None
Colombia

Do you have negative results from your research you’d like to share?

Paper statistics

Downloads
128
Abstract Views
1,594
Rank
399,871
PlumX Metrics